Current management of NAFLD/NASH

NAFLD is the most common cause of liver disease worldwide, and its prevalence is significantly increasing. Studies have shown that it is associated with comorbidities such as diabetes, metabolic syndrome and obesity. Early diagnosis and management are highly important and could modify the prognosis of the disease. Evaluating the possibility of multiple aetiologies and recognizing the additional causes of liver disease should be a part of the patient's initial assessment. There are no approved drug treatments as yet, so the main management strategies should involve lifestyle changes such as physical activity and dietary re-education.

Automated summary

NAFLD is the most common cause of liver disease globally, with increasing prevalence and associations with comorbidities such as diabetes, metabolic syndrome, and obesity. Early diagnosis and management are crucial, with lifestyle changes being the main management strategies due to the lack of approved drug treatments.